Kiniksa Pharmaceuticals, Ltd. (KNSA) Earnings
|
Expand Research on KNSA
| Next EPS Date | 7/28/26 | EPS Growth Rate | +30.4% |
|---|---|---|---|
| Average EPS % Beat Rate | +112.0% | Revenue Growth Rate | +43.8% |
| Average % Move 1-Wk after EPS | +22.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
7/28/26  |
Q226 | N/A | $0.30 | N/A | N/A | $225.48M | = | N/A | N/A | ||
| 4/28/26 | Q126 | $0.27 | $0.21 | +$0.06 | $214.27M | $207.12M | = |  | | Details | |
| 2/24/26 | Q425 | $0.17 | $0.35 | -$0.18 | $202.13M | $199.61M | = | | | Details | |
| 10/28/25 |
Q325 | N/A | $0.32 | N/A | N/A | $166.67M | = | N/A | N/A | ||
| 7/29/25 | Q225 | $0.23 | $0.19 | +$0.04 | $156.79M | $145.28M | = | | | Details | |
| 4/29/25 | Q125 | $0.11 | $0.02 | +$0.09 | $137.7M | $131.07M | = | | | Details | |
| 2/25/25 |
Q424 | N/A | $0.03 | N/A | N/A | $123.42M | = | N/A | N/A | ||
| 10/29/24 | Q324 | -$0.18 | $0.01 | -$0.19 | $112.21M | $110.29M | = | | | Details |
